• Why Attend?
  • Agenda
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • 2026 Sponsors
  • Media Centre
  • Why partner?
  • Contact Us

Why Attend?

A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

The programme will feature a range of speakers from the likes of Bristol Myers Squib, Otsuka, Cerevel Therapeutics, Merck, Daiichi Sankyo and many more, who through a variety of interactive session formats will offer insight on promoting successful clinical data management.

See What It's All About

Agenda

  • 24 Nov 2026
  • 25 Nov 2026
Expand All

8 AM

Registration and refreshments

9 AM

Chair’s opening remarks

Speakers

Giacomo Mordenti
Global Head of Data and Statistical Sciences for RWE and EG, Daiichi Sankyo

9:15 AM

KEYNOTE PANEL DISCUSSION Looking to the future: Trends, technology, and preparing for the era of connected, intelligent trials

  • Overviewing emerging trends and the current clinical data landscape to understand how organisations are adapting to increased trial complexity
  • Looking at the biggest operational and technology challenges and exploring practical solutions
  • Understanding expectations from data teams will be over the next 3–5 years to ensure your team is prepared

Moderator: Giacomo Mordenti, Global Head of Data and Statistical Sciences for RWE and EG, Daiichi Sankyo

Speakers

Giacomo Mordenti
Global Head of Data and Statistical Sciences for RWE and EG, Daiichi Sankyo
Craig Garmendia
Director of Quality Science & Strategy, AstraZeneca
Mats Sundgren
Senior Industry Scientific Director, The European Institute for Innovation through Health Data

10 AM

Reserved for event sponsor

10:30 AM

Clinical trials without boundaries: Bringing research closer to patients through technology and data

  • Using routine health data to improve study design and recruitment
  • Connecting EHRs with trial systems to reduce duplicate data entry
  • Practical outcomes from the eSource Scale-Up Task Force
  • Standardised KPIs and emerging evidence from five oncology centres
  • Scaling adoption through interoperability and collaboration

Speakers

Mats Sundgren
Senior Industry Scientific Director, The European Institute for Innovation through Health Data

11 AM

Morning refreshments and networking break

11:45 AM

From fragmented data to better decisions: Building trusted evidence at scale

  • Improving healthcare data capture to support reliable evidence generation
  • Enabling interoperability and scalability through standardisation and federated studies (e.g. OMOP)
  • Using advanced analytics to understand patient journeys, disease progression and treatment response
  • Applying AI to accelerate analytics, quality control and operational efficiency
  • Supporting precision medicine by identifying the right patients, treatments and interventions
  • Ensuring transparency, scientific rigour and governance throughout the evidence generation lifecycle

Speakers

Alexia Giannoula
Associate Director - Real World Data Scientist, AstraZeneca

12:15 PM

Using AI to unlock the evolution to Data Manager 2.0.

  • Data Manager 1.0 vs. 2.0: What if we could fundamentally change how data managers spend their time?
  • Better data at source: Can AI help us break the endless cycle of data cleaning and queries?
  • AI in action: Practical examples of what's already possible today

Speakers

Juan Munoz-Pujol
VP of RTSM, CALYX

12:45 PM

Lunch and networking

2 PM

FIRESIDE CHAT: The traps of AI: Bias, misrepresentation, and what to do about it in your clinical study

  • Identifying where AI bias can creep into clinical research, from data collection and analysis to patient selection and decision-making
  • Exploring the risks of AI-generated insights and inaccurate outputs in clinical trial settings
  • Examining the impact of poor quality or biased data on patient safety
  • Discussing practical approaches to identifying, mitigating and monitoring AI-related risks while maintaining transparency, accountability and trust in clinical research

Interviewer: Giacomo Mordenti, Global Head of Data and Statistical Sciences for RWE and EG, Daiichi Sankyo

Interviewee: Luana Lo Piccolo, Senior Advisor, AI Governance, Tech Law & Global Policy

Speakers

Giacomo Mordenti
Global Head of Data and Statistical Sciences for RWE and EG, Daiichi Sankyo
Luana Lo Piccolo
Senior Advisor, AI Governance, Tech Law & Global Policy

2:30 PM

From data collection to data reuse: preparing clinical trial data for future research and regulatory needs – Case study for biospecimen collection and reuse by GSK

Speakers

Seif Eddine Amara Madi
Senior Manager Clinical Labs Quality, GSK

3 PM

Practical lessons on AI experimentation to scalable delivery: Prioritisation, adoption and governance

Speakers

Julian Montero
AI and Automation Delivery Coordinator, Boehringer Ingelheim

3:30 PM

Afternoon refreshments and networking

4 PM

From Accreditation to Data Confidence: European Harmonisation for SoHO and ATMPs

  • Exploring how European accreditation and harmonisation initiatives align SoHO establishments, manufacturers and regulators around quality and traceability
  • Understanding the impact of the new SoHO Regulation on coding, long-term traceability, vigilance reporting and data management
  • Examining risk-based evidence requirements for clinical studies and their implications for data collection and registries
  • Identifying the practical steps needed to strengthen validated IT systems, data governance and GDPR-compliant processes

Speakers

Carlos Torrico León
Operations Manager, Banc de Sang i Teixits

4:30 PM

The Journey to Self-Healing Data: From Quality Rules to AI-Driven Data Correction

  • Moving beyond traditional data quality monitoring toward proactive and continuous quality management
  • Combining automated, rule-based correction with trusted data-quality controls
  • Exploring how AI can identify emerging data-quality violations and recommend appropriate corrections based on trusted data
  • Building a governed self-healing data approach that improves data reliability while maintaining appropriate human oversight

Speakers

Maryam Tahmooresi
Associate Data Intelligence Expert, Bayer

5 PM

END OF DAY ONE

8:30 AM

Registration and refreshments

9:20 AM

Chair’s opening remarks

Speakers

Andreas Seidl
Chief Scientific Officer, Formycon

9:30 AM

🗣️ INTERACTIVE BREAKFAST DISCUSSIONS

With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run for 30 minutes and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

Discussion 1 How can I design a robust risk-based clinical data framework for my clinical trial?
Hosted by: Giacomo De Simone, Chief Executive Officer, EndoLipiD Therapeutics
Discussion 2 What types of challenges are best to be solved with technology and ai, and what are the best ways to operationalise?
Discussion 3 Governing the vendor ecosystem in clinical trials: Strengthening oversight, data ownership, and performance in a multi-vendor world

Speakers

Giacomo De Simone
Chief Executive Officer, EndoLipiD Therapeutics

9:45 AM

Reserved for event sponsor

10:15 AM

Morning refreshments and networking break

11 AM

PANEL Clarifying roles and ownership to break down silos and connect clinical data teams

  • Aligning teams to breakdown down silos and encouraging collaboration between different departments to enhance clinical data processes
  • Planning early so teams align on clinical data strategy, scope, and expectations
  • Establishing clear roles and decision rights across functions to reduce rework and delays

Panel seat reserved for event sponsor

Speakers

Himanshu Sahu
Clinical Data Management Specialist, Nestlé Research – Nestlé Clinical Research Unit
Pablo Aguilar Cabadas
Associate Director Data Strategy - Global Development, Johnson & Johnson

11:30 AM

Reserved for event sponsor

12 PM

Reserved for GlobalData

12:45 PM

Lunch and networking

1:45 PM

INDUSTRY CASE STUDY From copilots to coworkers: A comprehensive guide on moving agentic AI from theory into everyday practice

  • Defining agentic AI and its capabilities to understand how it works and how it differs from automation and rule-based workflows
  • Exploring where agentic AI can safely and effectively operate withing regulated environments
  • Reviewing real-world use cases and how governance and oversight can enable successful adoption

Speakers

Farhad Rezazadeh
Senior Data Scientist and AI Engineer, Boehringer Ingleheim

2:15 PM

FIRESIDE CHAT Building a scalable clinical data strategies as a start-up

  • Designing a robust clinical data management plan when balancing limited resources
  • Weighing up outsourcing versus in house capabilities to support clinical trial plans and stick to timelines
  • Ensuring rigorous vendor oversight as a small biotech to ensure regulatory compliance

Speakers

Sara Gomez
Chief Technology Officer, InnoUp Farma

2:45 PM

Afternoon refreshments and networking

3:15 PM

Are you prepared for ICH E6(R3)?: Shifting focus towards a risk-based approach to keep compliant in an evolving regulatory environment

  • Understanding the key changes introduced in ICH E6(R3) and their impact on clinical research to ensure trial plans are compliant with new regulation
  • Understanding new good clinical practice expectations and the connectedness between adopting a risk-based approach
  • Looking at practical steps to prepare your team for successful implementation to avoid regulatory roadblocks

Speakers

Silvia Perez Torres
Director, Clinical Quality Compliance, AstraZeneca

3:45 PM

WORKSHOP Practical strategies to reduce patient and site burden through smarter and more meaningful data collection

Concept: This workshop equips attendees with practical methods on how to design meaningful data collection strategies that reduce burden on patients and sites. Attendees will learn how to distinguish endpoints effectively and apply practical techniques to simplify assessments without increasing risk

Takeaway: Attendees will leave with a repeatable, study-ready framework to streamline data collection and tactics to reduce burden while maintaining data quality

 

Panel seat reserved for event sponsor

Speakers

Brijesh Dubey
Data & AI Lead Engineer (Real World Data & Healthcare Intelligence), Sanofi
Pablo Aguilar Cabadas
Associate Director Data Strategy - Global Development, Johnson & Johnson

4:30 PM

END OF CONFERENCE

Speakers

Select a speaker to learn more

Back
Silvia Perez Torres
Director, Clinical Quality Compliance, AstraZeneca

I have a PH degree in Pharmaceutical sciences by the Barcelona University. I started my career as a researcher in Neurochemical department within the Barcelona Biomedical Research Institute (IIBB), where I developed my PH degree focused on Alzheimer’s disease and Inflammation.

Once I completed my Ph Degree in Neuroscience, I moved to the clinical industry, working most of my career in Data Management, first in a small CRO company and later in the pharma industry.

For along almost 12 years, I was managing phase III clinical trials acting as Global Data Manager Lead, coordinating end-to-end data management activities (including SDTM development) mainly outsourced to global CROs. Apart of the oversight of clinical trials, part of my role as an expert in DM was to lead standardization on E2E data and processes.

On 2018, I completely changed my role and moved to the Quality area. Since then, I’m Director on Clinical Quality Compliance. On this role, I’m providing quality support to Biometrics functions (including DM, Programming and Statistics roles). Among other activities, I’m giving quality related advice and guidance, overseeing quality issues, CAPA implementation and risk management. Coordinating and supporting audit and inspections, as well as preparing teams to be inspection ready at all time.

Since 2020, I’m Regulatory Considerations Expert Group DMEG Chair on the Association for Clinical Data Management. The aim of the Regulatory Considerations Expert Group looks at providing guidance information on several areas surrounding regulations. The expectations and recommendations on implementation and what data management needs to be prepared for in readiness for inspection.

Session Details:

Are you prepared for ICH E6(R3)?: Shifting focus towards a risk-based approach to keep compliant in an evolving regulatory environment

2026-11-25, 3:15 PM

View In Agenda
Next speaker
Back
Álex Turpin
PhD, Head AI Governance R&D, AstraZeneca
Next speaker
Back
Amulya Bondada
Head of Data Strategy and Framework, Bayer
Next speaker
Back
Farhad Rezazadeh
Senior Data Scientist and AI Engineer, Boehringer Ingleheim

Session Details:

INDUSTRY CASE STUDY From copilots to coworkers: A comprehensive guide on moving agentic AI from theory into everyday practice

2026-11-25, 1:45 PM

View In Agenda
Next speaker
Back
Giacomo De Simone
Chief Executive Officer, EndoLipiD Therapeutics

Session Details:

🗣️ INTERACTIVE BREAKFAST DISCUSSIONS

2026-11-25, 9:30 AM

View In Agenda
Next speaker
Back
Luana Lo Piccolo
Senior Advisor, AI Governance, Tech Law & Global Policy

Luana is a keynote speaker, board member, lecturer, and advisor specializing in Legal Tech, Artificial Intelligence, and Global Digital Governance. She supports businesses, governments, and international institutions in designing AI governance strategies that go beyond compliance to foster ethical leadership, resilience, and sustainable innovation. Working at the intersection of law, technology, and society, she has contributed to major digital regulations, including the EU AI Act and the Digital Services Act. Widely recognized for advancing responsible AI and tech accountability, Luana helps organizations transform governance into a source of strategic clarity and competitive advantage in an increasingly complex digital landscape.

In recognition of her impact, she was named Best Legal Strategist in Responsible AI & Regulatory Compliance by the Global Legal Association (2025) and Best Responsible AI Leader by the Responsible AI Institute (2024).

Session Details:

FIRESIDE CHAT: The traps of AI: Bias, misrepresentation, and what to do about it in your clinical study

2026-11-24, 2:00 PM

View In Agenda
Next speaker
Back
Rinaldo Wander Montalvão
Director of Artificial Intelligence, Gain Therapeutics
Next speaker
Back
Olga Martinez-Casares
Director Risk Management and Management Monitoring Europe and Emerging Markets, GSK

More than 20 years experience in the pharmaceutical industry. Passionate about clinical research. Apply this passion and the ability to integrate personal and cultural differences, to create high performing teams in a respectful environment. Constantly perform above and beyond the limits of a role. Natural developer as motivate others on the same principles. Comfortable working out of the comfort zone. Top performer. Continuous improvement mindset, I embrace the change quickly as an opportunity to move things forward from the status quo. Critical thinker. Agile learner looking for motivating and challenging opportunities.

Next speaker
Back
Sara Gomez
Chief Technology Officer, InnoUp Farma

Session Details:

FIRESIDE CHAT Building a scalable clinical data strategies as a start-up

2026-11-25, 2:15 PM

View In Agenda
Next speaker
Back
Pablo Aguilar Cabadas
Associate Director Data Strategy - Global Development, Johnson & Johnson

Session Details:

PANEL Clarifying roles and ownership to break down silos and connect clinical data teams

2026-11-25, 11:00 AM

Session Details:

WORKSHOP Practical strategies to reduce patient and site burden through smarter and more meaningful data collection

2026-11-25, 3:45 PM

View In Agenda
Next speaker
Back
Danai Bili
Lab Systems and Data Lead, Johnson & Johnson
Next speaker
Back
Himanshu Sahu
Clinical Data Management Specialist, Nestlé Research – Nestlé Clinical Research Unit

Himanshu Sahu is a Clinical Data Management Specialist at Nestle Clinical Research Unit with over 16 years of experience leading end‑to‑end clinical data management across global pharmaceutical and nutrition research. He is known for his expertise in data quality oversight, cross‑functional study leadership, and driving data‑strategy initiatives in collaboration with CROs and external service providers. A strong advocate of data storytelling, he leverages tools like Power BI to translate complex clinical data into actionable insights. His career includes key roles at Novartis, AstraZeneca, Alcon, Iqvia, and Cognizant, where he championed process optimization and innovation in data workflows. Himanshu holds an MSc in Biotechnology and a Postgraduate Certificate in Clinical Research & Data Management and is widely recognized for his strategic thinking and commitment to advancing data‑driven excellence in clinical research.

Session Details:

PANEL Clarifying roles and ownership to break down silos and connect clinical data teams

2026-11-25, 11:00 AM

View In Agenda
Next speaker
Back
Alessandro Vertone
Data Protection and Governance Specialist, Novartis
Next speaker
Back
Jurij Kodre
Head, Global, Data Management, Analytics, DS and AI Solutions, Sandoz Pharmaceuticals
Next speaker
Back
Brijesh Dubey
Data & AI Lead Engineer (Real World Data & Healthcare Intelligence), Sanofi

Session Details:

WORKSHOP Practical strategies to reduce patient and site burden through smarter and more meaningful data collection

2026-11-25, 3:45 PM

View In Agenda
Next speaker
Back
Mats Sundgren
Senior Industry Scientific Director, The European Institute for Innovation through Health Data

Mats Sundgren, PhD, MSc, is Senior Industry Scientific Director and co-founder of the European Institute for Innovation through Health Data (i~HD). He brings over 37 years of pharmaceutical industry experience spanning drug discovery and development, clinical science, health data, and artificial intelligence.

During 12 years as global lead for Electronic Health Record integration at AstraZeneca, he advanced the use of routinely collected healthcare data in clinical research. Through the i~HD eSource Scale-up Task Force, he brings together hospitals, sponsors and technology providers to develop practical guidance and standardised evidence supporting EHR-to-EDC adoption.

Mats is also co-founder of CLAIR, the Conference of Leadership for AI in Research, which explores how leadership, critical thinking and organisational capabilities must evolve alongside AI. He chairs the IMIT Research Foundation (Institute for Management of Innovation and Technology) and serves on the board of the Center for Health Governance at the University of Gothenburg. He holds advisory roles with IgniteData and ZS Associates.

His work includes more than 80 publications, books and patents across life sciences, economics and social sciences, connecting technological innovation with organisational change and practical implementation.

Session Details:

KEYNOTE PANEL DISCUSSION Looking to the future: Trends, technology, and preparing for the era of connected, intelligent trials

2026-11-24, 9:15 AM

Session Details:

Clinical trials without boundaries: Bringing research closer to patients through technology and data

2026-11-24, 10:30 AM

View In Agenda
Next speaker
Back
Alexia Giannoula
Associate Director - Real World Data Scientist, AstraZeneca

Session Details:

From fragmented data to better decisions: Building trusted evidence at scale

2026-11-24, 11:45 AM

View In Agenda
Next speaker
Back
Craig Garmendia
Director of Quality Science & Strategy, AstraZeneca

Session Details:

KEYNOTE PANEL DISCUSSION Looking to the future: Trends, technology, and preparing for the era of connected, intelligent trials

2026-11-24, 9:15 AM

View In Agenda
Next speaker
Back
Shilpa Lewandowski
Director, Study Management Organisation, Oncology, AstraZeneca
Next speaker
Back
Carlos Torrico León
Operations Manager, Banc de Sang i Teixits

Session Details:

From Accreditation to Data Confidence: European Harmonisation for SoHO and ATMPs

2026-11-24, 4:00 PM

View In Agenda
Next speaker
Back
Julian Montero
AI and Automation Delivery Coordinator, Boehringer Ingelheim

Session Details:

Practical lessons on AI experimentation to scalable delivery: Prioritisation, adoption and governance

2026-11-24, 3:00 PM

View In Agenda
Next speaker
Back
Juan Munoz-Pujol
VP of RTSM, CALYX

Session Details:

Using AI to unlock the evolution to Data Manager 2.0.

2026-11-24, 12:15 PM

View In Agenda
Next speaker
Back
Giacomo Mordenti
Global Head of Data and Statistical Sciences for RWE and EG, Daiichi Sankyo

Session Details:

Chair’s opening remarks

2026-11-24, 9:00 AM

Session Details:

KEYNOTE PANEL DISCUSSION Looking to the future: Trends, technology, and preparing for the era of connected, intelligent trials

2026-11-24, 9:15 AM

Session Details:

FIRESIDE CHAT: The traps of AI: Bias, misrepresentation, and what to do about it in your clinical study

2026-11-24, 2:00 PM

View In Agenda
Next speaker
Back
Andreas Seidl
Chief Scientific Officer, Formycon

Andreas Seidl has 25 years of experience in development of biosimilars and NBEs in the biopharma industry. He is Chief Scientific Officer at Formycon AG and in this role responsible for the overall scientific strategy of the company. In the management board of the company he is accountable for pre-clinical and clinical development of the biosimilar pipeline of the company as well as drug product development, bioanalytics and IP. Before joining Formycon he was from 2019 to 2022 COO at Leukocare AG/Munich. In the managing board of Leukocare he was responsible for research & development activities, intellectual property and quality management. Until 2019 he held different local and global positions at Hexal AG, Sandoz Biopharmaceuticals and Novartis in the area of development of biopharmaceuticals. In the early days of biosimilars he coordinated the pioneering analytical and pharmaceutical development activities of the first wave of biosimilars and contributed so far to the development and approval of eleven biosimilar products. He holds a Ph.D. in the area of protein analysis and mass spectrometry from the University of Constance/Germany where he also studied chemistry.

Session Details:

Chair’s opening remarks

2026-11-25, 9:20 AM

View In Agenda
Next speaker
Back
Jasper Morley
Drugs Intelligence Analyst at GlobalData

Jasper Morley, senior Drugs Intelligence Analyst at GlobalData. His primary responsibilities include managing and maintaining GlobalData's Drugs Database, analyzing marketed drug information, and producing analytical market insight reports. In addition, Jasper provides timely client support and performs database quality checks. Prior to joining GlobalData, Jasper worked as a Medical Affairs associate at Merz Pharma UK, focusing on Medical Information and Pharmacovigilance activities within the neurology and dermatology therapy areas. More recently, Jasper was employed by the University College London Hospitals NHS Foundation Trust, working within the research facilities of the Cancer Clinical Trials Unit.

Next speaker
Back
Lei Xu
VP, Head of Biometrics, uniQure
Next speaker
Back
Maryam Tahmooresi
Associate Data Intelligence Expert, Bayer

Session Details:

The Journey to Self-Healing Data: From Quality Rules to AI-Driven Data Correction

2026-11-24, 4:30 PM

View In Agenda
Next speaker
Back
Seif Eddine Amara Madi
Senior Manager Clinical Labs Quality, GSK

Session Details:

From data collection to data reuse: preparing clinical trial data for future research and regulatory needs – Case study for biospecimen collection and reuse by GSK

2026-11-24, 2:30 PM

View In Agenda
Next speaker

Plan Your Visit

Venue

Hotel Santos Porta Fira, Barcelona Pl. d'Europa, 45, 08908 L'Hospitalet de Llobregat, Barcelona, Spain

• Discounted room rate: EUR 145 per room per night for single occupancy, with breakfast included
• Use code: CDMI26

Accommodation

Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

2026 Sponsors

Select a sponsor to learn more

Session Sponsor

Exhibitors

Why partner?

Contact us to become a partner

Partnership Opportunities

We work with you to design a bespoke package to meet your business needs, where you could:

  • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
  • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
    Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
  • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

Event reach

  • 100+ attendees each year
  • 80% attendees C-suite level

 

Take a look at our current sponsors

Media Centre

Become A Media Partner

 A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES

The programme will feature a range of speakers from the likes of Bristol Myers Squib, Otsuka, Cerevel Therapeutics, Merck, Daiichi Sankyo and many more, who through a variety of interactive session formats will offer insight on promoting successful clinical data management.

See What It's All About

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Conor Taylor

Sponsorship Sales Manager

+44 (0) 20 7936 6870

SPEAKER ENQUIRIES

Maya Hudson

Deputy Head of Production

+44 204540 7766

MARKETING ENQUIRIES

Karina Gomez

Deputy Head of Marketing

DELEGATE ENQUIRIES

Sunny Saikia

VIP Delegate Manager

SPONSORSHIP ENQUIRIES


Sponsorship Sales Manager

Conor Taylor


+44 (0) 20 7936 6870

SPEAKER ENQUIRIES


Deputy Head of Production

Maya Hudson


+44 204540 7766

MARKETING ENQUIRIES


Deputy Head of Marketing

Karina Gomez


 

DELEGATE ENQUIRIES


VIP Delegate Manager

Sunny Saikia